41343 Safety of Amlitelimab in a Phase 2a Clinical Trial of Patients With Moderate-to-Severe Atopic Dermatitis

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2023
This article has no abstract
Epistemonikos ID: 1eee0cbba14e6419d54f3546c40c9d044267541a
First added on: Dec 07, 2023